Transcatheter Aortic Valve Replacement Market Share | TAVR Industry Growth, 2026

1. Welcome To DataIntelo

2. Transcatheter Aortic Valve Replacement Market Share | TAVR Industry Growth, 2026 The global Transcatheter Aortic Valve Replacement (TAVR) market size was valued at USD 2.6 billion in 2017. It is anticipated to rise at a CAGR of 21% over the forecast period 2019-2026. Rising number of patients across the globe suffering from cardiovascular diseases is escalating the growth. Transcatheteraortic valve replacement (TAVR) is a minimally invasive procedure and known as transcatheter aortic valve implantation (TAVI). It can be used in the treatment of aortic stenosis. Simply put, the procedure removes the old and damaged valve and inserts the replacement valve into aortic valve’s position. This procedure is approved by FDA and is basically for people with symptomatic aortic stenosis. The TAVR is performed using two different approaches that enables the surgeon to decide between the best and safe practice to access the valve. In the first approach, the TAVR procedure is initiated by entering through a femoral artery, usually called as transfemoral approach, which does not incorporate any surgical incision in the chest. In the second approach, TAVR is generally performed using a minimally invasive surgery with a small incision in the chest, arriving via a large artery in the chest or through left ventricle, which is usually known as transapical approach.

3. Transcatheter Aortic Valve Replacement (TAVR) Market Trends, Drivers and Opportunities: The Transcatheter Aortic Valve Replacement (TAVR) market is majorly driven by rise in geriatric population with chronic and acute heart conditions. Sedentary lifestyle is a major factor in developing acute heart conditions with a risk of developing valvular heart disease. Transcatheter heart valve is used in the procedure of TAVR for patients unable to withstand open-heart surgeries. For instance, patients with diabetic conditions are bound to face complications during open-heart surgery owing to which TAVR tends to be a feasible solution. Usually, the treatment is preferred since it incurs low recovery time usually less than seven to eight days. Hence, patient preference for Transcatheter aortic valve replacement surgery is more likely to drive the market growth. Significant investment for research & development activities, product launches are likely to create lucrative opportunities. In addition, rise in adoption of minimally invasive surgery followed by technological advancements is projected to result in high efficiency. Request for Free Sample: https://dataintelo.com/request-sample/?reportId=382

4. Transcatheter Aortic Valve Replacement (TAVR) Market Segment Insights: By Procedure: The transcatheter aortic valve replacement market can be segmented into transapical, transfemoral, and transaortic. Transfemoral aortic valve replacement led the segment in 2018 owing to enhanced technology, facilitates early recovery and minimizes hospital stay. By Geography: The market is segmented into North America, South America, Europe, Asia Pacific, Middle East and Africa. U.S. dominated the global market in 2018 accounting for a significant market share. Factors such as significant adoption of technically evolved products and favourable reimbursement policies have led in a high regional market growth. In addition, government support to patients have encouraged them to undergo TAVR procedures which directly strengthens the demand factors in the market. Competitive Landscape: The key players in the transcatheter aortic valve replacement market include Boston Scientific Corp; Edwards Lifesciences, and St Jude Medical Inc., Mergers & acquisitions, and significant funding for R&D activities to minimize complications and result in business expansions are some of the strategies adopted by vendors. Discover More @ https://dataintelo.com

5. Thank You